Strategies for Maintaining Long-Term GLP-1 Safety Several practical strategies can help maintain the long-term safety and tolerability of GLP-1 therapy while improving adherence
These differences matter clinically: larger average weight loss translates into bigger improvements in blood pressure, glycemic measures, sleep apnea metrics, mobility, and quality of life for many patients
The majority of users are able to safely and effectively use the drug to manage their condition, with minimal or manageable side effects
If appetite decreases severely, you might be inadvertently consuming less
a change from baseline in fasting plasma glucose, insulin, glucagon, fasting C-peptide, insulin resistance, beta-cell function, body weight, waist circumference, and BMI
Large trials suggest cardiovascular risk may improve with some agents, and semaglutide showed favorable cardiometabolic signals